https://orcid.org/0000-0001-8622-3480
References
- DiMarzio P, Peila R, Dowling O, et al. Smoking and alcohol drinking effect on radiotherapy associated risk of second primary cancer and mortality among breast cancer patients. Cancer Epidemiol. 2018;57:97–103. doi:10.1016/j.canep.2018.10.00230359894
- Huang YJ, Huang TW, Lin FH, Chung CH, Tsao CH, Chien WC. Radiation therapy for invasive breast cancer increases the risk of second primary lung cancer: a Nationwide Population-Based Cohort Analysis. J Thorac Oncol. 2017;12(5):782–790. doi:10.1016/j.jtho.2017.01.02128214559
- Withrow DR, Morton LM, Curtis RE, Schonfeld SJ, Berrington de González A. Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers. Breast Cancer Res Treat. 2017;166(1):299–306. doi:10.1007/s10549-017-4410-628744752
- Mellemkjaer L, Friis S, Olsen JH, et al. Risk of second cancer among women with breast cancer. Int J Cancer. 2006;118(9):2285–2292. doi:10.1002/ijc.2165116342146
- Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev. 2007;16(3):566–571. doi:10.1158/1055-9965.EPI-06-078217372253
- Hammond ME, Hayes DF, Dowsett M. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (vol 134, pg 907, 2010). Arch Pathol Lab Med. 2010;134(8):1101. doi:10.5858/134.6.907
- Kirova YM, De Rycke Y, Gambotti L, Pierga JY, Asselain B, Fourquet A; Inst Curie Breast Canc Study G. Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer. 2008;98(5):870–874. doi:10.1038/sj.bjc.660424118268495
- Giuliano AE, Edge SB, Hortobagyi GN. Eighth edition of the AJCC cancer staging manual: breast cancer. Ann Surg Oncol. 2018;25(7):1783–1785. doi:10.1245/s10434-018-6486-629671136
- Kay FU, Kandathil A, Batra K, Saboo SS, Abbara S, Rajiah P. Revisions to the Tumor, Node, Metastasis staging of lung cancer (8th edition): rationale, radiologic findings and clinical implications. World J Radiol. 2017;9(6):269–279. doi:10.4329/wjr.v9.i6.26928717413
- Kim SW, Kong KA, Kim D-Y, Ryu YJ, Lee JH, Chang JH. Multiple primary cancers involving lung cancer at a single tertiary hospital: clinical features and prognosis. Thorac Cancer. 2015;6(2):159–165. doi:10.1111/1759-7714.1215826273353
- Wang R, Yin Z, Liu L, et al. Second primary lung cancer after breast cancer: a population-based study of 6269 women. Front Oncol. 2018;8:427. doi:10.3389/fonc.2018.0042730356721
- Chen -Y-Y, Huang Y-J, Huang H-K, et al. The prognostic factors of recurrence and survival in female patients with lung adenocarcinoma and breast cancer. J Cancer Res Clin Oncol. 2020;146(5):1299–1306. doi:10.1007/s00432-020-03162-532107626
- You J, Wei S. Progress in resistance markers of commonly used chemotherapeutics for lung cancer and individualized medication. J Pract Oncol. 2008;01:82–86.
- Buumba BM, Bhardwaj S, Kaur P. A critical review on recent development of techniques and drug targets in the management of breast cancer. Mini Rev Med Chem. 2021;21. doi:10.2174/1389557521666210126125200
- Pathak M, Deo SVS, Dwivedi SN, Thakur B, Sreenivas V, Rath GK. Regimens of neo-adjuvant chemotherapy in the treatment of breast cancer: a systematic review & network meta-analysis with PRISMA-NMA compliance. Crit Rev Oncol Hematol. 2020;153.